Dryden Capital’s HPX Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 HPX.WS Stock Holding History

Dryden Capital’s Portfolio HPX.WS Stock Details HPX.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-261,900	Closed	-$110K	–	38
2022 Q4	$110K	Sell	261,900 -27,900	-10%	-$10.4K	0.15%	23
2022 Q3	$70K	Buy	289,800 +27,900	+11%	+$8.3K	0.06%	33
2022 Q2	$43K	Hold	261,900	–	–	0.03%	42
2022 Q1	$46K	Hold	261,900	–	–	0.03%	42
2021 Q4	$141K	Buy	+261,900	New	+$176K	0.1%	34

Dryden Capital's HPX.WS Position: Q1 2023 in Review

Dryden Capital sold out of HPX Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (HPX.WS) in Q1 2023, closing a stake of 261,900 shares — an estimated $110K sold.

Dryden Capital first reported a position in HPX.WS in Q4 2021 and held it in 5 quarters. The position peaked at $141K in Q4 2021. 0 funds tracked by Wall St. Rank hold HPX.WS as of Q1 2023.

Dryden Capital reported no remaining HPX Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q1 2023 after selling out during the quarter.
Dryden Capital sold 261,900 HPX Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q1 2023, an estimated $110K.
Dryden Capital first reported a position in HPX Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q4 2021 and held it in 5 quarters.
Dryden Capital's HPX Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $141K in Q4 2021.
0 funds tracked by Wall St. Rank held HPX Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q1 2023.

Based on Dryden Capital's 13F filing for Q1 2023, filed 15 May 2023.